Glycosaminoglycans and proteoglycans /

Glycosaminoglycans and proteoglycans / / edited by Barbara Mulloy.

Show other versions (1)

Proteoglycans (PGs) are glycoconjugates in which a protein or peptide core is substituted with polysaccharide chains known as glycosaminoglycans (GAGs). The GAG sidechains carry a significant proportion of the functionality of PGs, interacting with many proteins to form structural units in the extra...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Mulloy, Barbara,
Place / Publishing House:Basel, Switzerland : : MDPI,, [2018]
©2018
Year of Publication:2018
Language:English
Physical Description:1 online resource (v, 215 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993561943604498
ctrlnum (CKB)5400000000000265
(NjHacI)995400000000000265
(EXLCZ)995400000000000265
collection bib_alma
record_format marc
spelling Glycosaminoglycans and proteoglycans / edited by Barbara Mulloy.
Basel, Switzerland : MDPI, [2018]
©2018
1 online resource (v, 215 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Proteoglycans (PGs) are glycoconjugates in which a protein or peptide core is substituted with polysaccharide chains known as glycosaminoglycans (GAGs). The GAG sidechains carry a significant proportion of the functionality of PGs, interacting with many proteins to form structural units in the extracellular matrix and to modulate the transport and signalling of small proteins acting as morphogens, growth factors and cytokines. Purified GAGs such as heparin and hyaluronan are in common use as therapeutic agents, with many more PG-based natural products, synthetic and semi-synthetic mimetics on the way; in addition, potential therapeutic strategies involving PG/GAG biosynthesis and degradation as targets are currently in development.
Includes bibliographical references.
Glycosaminoglycans.
Mulloy, Barbara, editor.
language English
format eBook
author2 Mulloy, Barbara,
author_facet Mulloy, Barbara,
author2_variant b m bm
author2_role TeilnehmendeR
title Glycosaminoglycans and proteoglycans /
spellingShingle Glycosaminoglycans and proteoglycans /
title_full Glycosaminoglycans and proteoglycans / edited by Barbara Mulloy.
title_fullStr Glycosaminoglycans and proteoglycans / edited by Barbara Mulloy.
title_full_unstemmed Glycosaminoglycans and proteoglycans / edited by Barbara Mulloy.
title_auth Glycosaminoglycans and proteoglycans /
title_new Glycosaminoglycans and proteoglycans /
title_sort glycosaminoglycans and proteoglycans /
publisher MDPI,
publishDate 2018
physical 1 online resource (v, 215 pages) : illustrations
isbn 3-03842-836-1
callnumber-first A - General Works
callnumber-subject AS - Academies
callnumber-label AS284
callnumber-sort AS 3284 G593 42018
illustrated Illustrated
dewey-hundreds 500 - Science
dewey-tens 590 - Animals (Zoology)
dewey-ones 599 - Mammals
dewey-full 599.322
dewey-sort 3599.322
dewey-raw 599.322
dewey-search 599.322
work_keys_str_mv AT mulloybarbara glycosaminoglycansandproteoglycans
status_str n
ids_txt_mv (CKB)5400000000000265
(NjHacI)995400000000000265
(EXLCZ)995400000000000265
carrierType_str_mv cr
is_hierarchy_title Glycosaminoglycans and proteoglycans /
author2_original_writing_str_mv noLinkedField
_version_ 1764993670119948289
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01707nam a2200301 i 4500</leader><controlfield tag="001">993561943604498</controlfield><controlfield tag="005">20230224115427.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230224s2018 sz a ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03842-836-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000000265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000000265</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000000265</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">AS284</subfield><subfield code="b">.G593 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">599.322</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Glycosaminoglycans and proteoglycans /</subfield><subfield code="c">edited by Barbara Mulloy.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI,</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (v, 215 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Proteoglycans (PGs) are glycoconjugates in which a protein or peptide core is substituted with polysaccharide chains known as glycosaminoglycans (GAGs). The GAG sidechains carry a significant proportion of the functionality of PGs, interacting with many proteins to form structural units in the extracellular matrix and to modulate the transport and signalling of small proteins acting as morphogens, growth factors and cytokines. Purified GAGs such as heparin and hyaluronan are in common use as therapeutic agents, with many more PG-based natural products, synthetic and semi-synthetic mimetics on the way; in addition, potential therapeutic strategies involving PG/GAG biosynthesis and degradation as targets are currently in development.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Glycosaminoglycans.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mulloy, Barbara,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 00:32:30 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-10-31 22:37:04 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338803880004498&amp;Force_direct=true</subfield><subfield code="Z">5338803880004498</subfield><subfield code="8">5338803880004498</subfield></datafield></record></collection>

Similar Items